Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$21,413,988
+$366,482 QoQ
Shares Held
84,317
-2.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#715
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HANTZ FINANCIAL SERVICES, INC. holds $94,295,990 across 14 Drug Manufacturers - General names. JNJ ranks #1 (22.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
84,317 | $21,413,988 | |
| 2 | LLY |
ELI LILLY & Co
|
10,017 | $12,014,691 | |
| 3 | ABBV |
AbbVie Inc.
|
45,381 | $11,419,674 | |
| 4 | NVS |
Novartis AG
|
68,779 | $10,779,044 | |
| 5 | MRK |
Merck & Co., Inc.
|
66,636 | $8,562,726 | |
| 6 | GSK |
GSK plc
|
159,568 | $8,364,554 | |
| 7 | NVO |
Novo Nordisk A S
|
117,306 | $5,623,649 | |
| 8 | AZN |
Astrazeneca PLC
|
23,610 | $4,476,928 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,413,988 | 84,317 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $21,047,506 | 86,105 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $17,886,895 | 86,431 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $16,880,636 | 91,040 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $14,461,300 | 94,673 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $16,293,945 | 98,251 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $14,727,522 | 101,836 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $17,337,016 | 106,979 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $16,293,332 | 111,476 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $18,287,871 | 115,607 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $19,705,666 | 125,722 | Shares | Sole | 2024-08-06 | |
| 2023-09-30 | $21,085,123 | 135,378 | Shares | Sole | 2024-08-06 | |
| 2023-06-30 | $22,118,603 | 133,631 | Shares | Sole | 2024-08-06 | |
| 2023-03-31 | $20,700,405 | 133,551 | Shares | Sole | 2024-08-06 | |
| 2022-12-31 | $23,382,453 | 132,366 | Shares | Sole | 2024-08-06 | |
| 2022-09-30 | $19,186,632 | 117,450 | Shares | Sole | 2024-08-06 | |
| 2022-06-30 | $20,396,964 | 114,906 | Shares | Sole | 2024-08-06 | |
| 2022-03-31 | $19,636,906 | 110,799 | Shares | Sole | 2024-08-06 | |
| 2021-12-31 | $17,993,313 | 105,181 | Shares | Sole | 2024-08-06 | |
| 2021-09-30 | $16,290,666 | 100,871 | Shares | Sole | 2024-08-06 | |
| 2021-06-30 | $14,197,787 | 86,183 | Shares | Sole | 2024-08-06 | |
| 2021-03-31 | $13,474,234 | 81,985 | Shares | Sole | 2024-08-06 | |
| 2020-12-31 | $13,083,628 | 83,134 | Shares | Sole | 2024-08-06 | |
| 2020-09-30 | $12,091,438 | 81,216 | Shares | Sole | 2024-08-06 | |
| 2020-06-30 | $11,607,037 | 82,536 | Shares | Sole | 2024-08-06 | |
| 2020-03-31 | $10,488,039 | 79,982 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||